M&A Advisor for Dental Practice Sales: 2026 DSO Buyer Sell-Side Guide
Start a Conversation

M&A Advisor for Dental Practice Sales: 2026 DSO Buyer Sell-Side Guide

M&A Advisor for Dental Practice Sales: How to Pick the Right Firm for Your DSO Exit

M&A Advisor for Dental Practice Sales: How to Pick the Right Firm for Your DSO Exit
M&A Advisor for Dental Practice Sales: 2026 DSO Buyer Sell-Side Guide

By CT Acquisitions Editorial Team, reviewed by senior M&A advisors. Last reviewed: June 2026.

An M&A advisor for a dental practice sale is a sell-side firm that runs a full competitive process to Dental Service Organizations (DSOs), private equity platforms, and strategic multi-doctor groups, then structures the deal (cash, rollover equity, earnouts, MSO/PC splits) to maximize your after-tax proceeds. If your practice generates over roughly $750,000 in adjusted EBITDA, or you own two or more locations, you have moved past what a solo-practice broker can deliver and into M&A advisor territory. This guide covers the 2026 DSO buyer landscape, real dental EBITDA multiples by practice tier, how to shortlist firms, the deal structures DSOs actually use, and the specific questions to ask before signing an engagement letter.

What is an M&A advisor for a dental practice, and how is that different from a dental broker?

An M&A advisor for a dental practice runs an auction-style sell-side process to institutional buyers (DSOs, PE-backed platforms, family offices) using confidential information memoranda, a data room, buyer lists of 30 to 100 targeted acquirers, and structured bidding rounds. A dental broker, by contrast, typically markets solo practices to individual dentist buyers via listings on sites like DentalTown or ADS Transitions, then handles a single-buyer negotiation.

The distinction matters because the buyer pool, deal mechanics, and price you can realize are different in each channel. A dentist buyer of a solo practice will pay based on collections and cash flow using bank financing (often SBA 7(a) loans capped at $5M, see SBA 7(a) program) and personal guarantees. A DSO or PE-backed platform buys off adjusted EBITDA, uses institutional debt, and layers in rollover equity, holdbacks, and earnouts that only an M&A advisor and a transactional attorney can properly negotiate. The Dykema 2024 Dental Service Organization Industry Report notes DSO transaction volume has grown at a double-digit compound rate over the past decade (Dykema DSO Industry Report).

The American Dental Association’s Health Policy Institute reports that dentist ownership of practices has fallen from 84.7% in 2005 to 73.0% by 2022, driven almost entirely by DSO consolidation of larger practices (ADA Health Policy Institute, 2024). If you are selling to a DSO or PE-backed platform, you need an M&A advisor. If you are selling a sub-$500K collections solo practice to a young dentist, a traditional dental broker is usually the correct tool and costs less.

When you need an M&A advisor versus a dental practice broker

Use an M&A advisor when your adjusted EBITDA exceeds roughly $750,000, when you have two or more locations, when you have already been contacted by DSOs, or when you want to keep post-close equity in a larger consolidated platform. Use a dental broker when you have a single location, sub-$500K collections, and want to sell to a local dentist buyer.

Practice profile Best advisor type Typical buyer pool Typical fee
Solo, under $500K collections Dental broker (ADS, Henry Schein PPT, Menlo Transitions) Individual dentist 8-10% of price
Solo, $500K-$1.5M collections Broker OR boutique M&A advisor Local dentist or small DSO 6-10% of price
Solo, $1.5M+ collections OR EBITDA over $750K M&A advisor (dental-fluent) DSO, PE platform Lehman formula or fixed + success
Multi-location group, 2-9 offices M&A advisor (LMM specialist) DSO, PE platform, family office Retainer + 2-5% success
Multi-location group, 10+ offices Middle-market investment bank PE fund, strategic DSO Retainer + 1-3% success

What is a DSO, and who are the largest DSO buyers of dental practices in 2026?

A Dental Service Organization (DSO) is a corporate management entity that owns the non-clinical assets of a dental practice (real estate leases, equipment, billing, HR, marketing, procurement) while a Professional Corporation (PC) owned by licensed dentists holds the clinical license and treats patients. This MSO/PC split exists because 33 states prohibit the corporate practice of dentistry, meaning a non-dentist entity cannot own the clinical side of a practice (state Dental Practice Acts).

DSOs and their PE sponsors have driven the vast majority of dental practice consolidation since 2015. Bain & Company’s 2024 Global Healthcare Private Equity Report identified dental services as one of the most active healthcare M&A subsectors, with roll-up activity concentrated in general dentistry, orthodontics, oral surgery, and pediatric dentistry (Bain Global Healthcare PE Report 2024).

Top DSO acquirers active in 2026

Beyond the platforms above, roughly two dozen smaller regional DSOs and PE-backed roll-ups actively acquire practices, particularly in the Southeast, Texas, Arizona, and the Carolinas. Your M&A advisor’s job is to run a competitive process across the right subset of these buyers, not to accept the first inbound offer.

What EBITDA multiples do DSOs pay for dental practices in 2026?

DSO acquisition multiples in 2026 typically range from 5x to 7x adjusted EBITDA for a solo general practice, 7x to 9x for a two-to-four-doctor group, 8x to 11x for a five-to-nine-location regional group, and 10x to 14x for platform-scale groups with over 10 locations and $10M+ EBITDA. Specialty practices (orthodontics, oral surgery, endodontics, pediatric) generally trade at a one-to-three-turn premium to general dentistry due to higher margins and stickier patient bases.

Multiples compressed roughly one to two turns from 2021-2022 peaks as interest rates rose. The Federal Reserve raised the federal funds rate from near zero in March 2022 to a 5.25-5.50% target by July 2023, and rates remained at that level for over a year before cuts began in September 2024 (Federal Reserve FOMC actions; FRED effective federal funds rate). Higher debt costs directly compressed what leveraged DSO buyers could pay. As rates have eased in 2025-2026, dental M&A activity has recovered but multiples remain below the frothy 2021 peaks. PitchBook’s healthcare services M&A quarterly reports have tracked this multiple compression across dental and other physician-services subsectors (PitchBook Healthcare Services Report Q4 2024).

2026 dental practice EBITDA multiple ranges by tier

Practice tier Adjusted EBITDA 2026 DSO multiple range Cash-at-close typical Rollover equity typical
Solo GP, sub-scale $250K-$500K 4.0x-5.5x 85-95% 0-10%
Solo GP, scale $500K-$1M 5.5x-7.0x 75-85% 10-20%
Two-to-four doctor group $1M-$3M 7.0x-9.0x 70-80% 15-25%
Regional group, 5-9 offices $3M-$8M 8.0x-11.0x 65-75% 20-30%
Platform, 10+ offices $8M-$20M+ 10.0x-14.0x 60-70% 25-35%
Orthodontic solo $500K-$2M 7.0x-10.0x 75-85% 15-25%
Orthodontic group $2M-$10M 9.0x-13.0x 65-75% 20-30%
Oral surgery group $2M-$15M 10.0x-14.0x 65-75% 25-35%
Pediatric dental group $1M-$8M 8.0x-12.0x 65-75% 20-30%
Endodontic group $1M-$6M 9.0x-13.0x 65-75% 25-30%

The ranges above reflect CT Acquisitions internal transaction observations and cross-referenced buyer indications of interest across 2024-2026. Individual deals vary by geography (Sun Belt premiums), insurance mix (fee-for-service and PPO trade higher than heavy Medicaid), doctor tenure post-close, and multi-year revenue trajectory.

For the mechanics of translating collections into adjusted EBITDA, see how to value a business for the full add-back methodology.

What add-backs count when calculating adjusted EBITDA for a dental practice?

Legitimate add-backs to reported EBITDA in a dental practice sale typically include: owner-dentist compensation above market (replaced with a market rate for an associate), owner personal expenses run through the business (auto, travel, meals, family payroll), one-time repairs or equipment write-offs, above-market rent paid to owner-controlled real estate LLCs, non-recurring legal or consulting fees, and pandemic-related PPP or ERC amounts.

Aggressive or unsupportable add-backs are the single most common reason a deal drops in price during due diligence. If your reported EBITDA is $600K but you are pitching the practice at $1.1M adjusted EBITDA, expect the buyer’s quality-of-earnings (QoE) analysis to strip out $200K-$400K. Get an independent QoE prepared by a firm like BDO Transaction Advisory, Grant Thornton, RSM US, Cherry Bekaert, or a dental-specialist accountant before you go to market. A pre-sale QoE typically costs $25,000 to $60,000 and pays for itself several times over by defending your multiple in negotiations.

How do DSO deal structures actually work? (Cash, rollover equity, earnouts, escrow)

A DSO acquisition of a dental practice is almost never an all-cash purchase. The standard structure is: 60-85% cash at close, 10-30% rollover equity into the DSO’s holdco parent, a 1-3 year earnout tied to post-close EBITDA maintenance, a working capital adjustment, and a 10-15% indemnification escrow held for 12-24 months against representation and warranty breaches. Each component has to be negotiated with the same intensity as the headline price.

Rollover equity: what you actually get

Rollover equity is the portion of your sale proceeds that you reinvest into equity of the acquiring DSO’s parent holding company, typically at the same valuation the DSO itself was valued at in its most recent PE fundraise. If the DSO trades at 12x EBITDA and you sold your practice at 8x, your rollover dollars effectively convert into shares of a 12x asset, creating a paper “second bite” opportunity if the DSO exits at a higher multiple in three-to-seven years.

This second bite can be lucrative or worthless depending on execution. Bain & Company research on private equity “second bite” outcomes shows meaningful dispersion: some rollover holders have realized 2x-5x on their rollover dollars in successful DSO exits, while others have taken write-downs or seen liquidity delayed by five-plus years when platforms miss growth targets (Bain Global Private Equity Report).

Rollover terms your M&A advisor must negotiate: preferred-versus-common share class, tag-along rights (you get to sell when the sponsor sells), drag-along protections (you cannot be forced out below a floor), a put right at a defined multiple after N years, dividend or preferred return treatment, and information rights so you can actually see how the platform is performing.

Earnouts: how DSOs use them and how to protect yourself

An earnout is a portion of purchase price contingent on the practice hitting specific EBITDA, collections, or new-patient targets in the 12-36 months after close. DSOs use earnouts to bridge valuation gaps and to keep selling dentists motivated during the transition. A typical dental earnout is 10-25% of total consideration, measured annually, with pro-rata catch-up if a miss is followed by a beat.

Earnout risk sits almost entirely on the seller because the buyer controls operations post-close. Standard defensive terms include: EBITDA measured on a defined “same-store” basis, protection against buyer expense allocation (no corporate overhead loads onto your P&L), acceleration on a change of control, a defined dispute-resolution mechanism with an independent accounting firm, and no gating of the earnout on subjective performance metrics. The American Bar Association’s private target M&A deal points studies track earnout prevalence and terms across US private-target transactions (ABA M&A Committee Deal Points Studies). See earnout definition for the underlying mechanics.

Escrow, holdback, and working capital adjustment

A 10-15% indemnification escrow is standard on DSO deals, held for 12-24 months against breaches of the seller’s representations (accurate financials, no undisclosed litigation, tax filings current, no HIPAA breaches per HHS OCR Breach Notification Rule, no material contract defaults, no undisclosed regulatory issues). Representation and warranty insurance (RWI) is common on deals over $10M enterprise value, letting you shrink the escrow to 0.5-1% of deal value and shift the tail risk to an insurer. Marsh McLennan’s Transactional Risk Insurance report tracks RWI market pricing and utilization (Marsh Transactional Risk Insurance). For the mechanics of escrow negotiation, see escrow and holdback structures.

The working capital adjustment, or “peg,” is the dollar-for-dollar true-up between the target net working capital at signing and actual net working capital at close. In a dental practice, this is mainly accounts receivable minus accounts payable, unearned revenue on prepaid orthodontic contracts, and dental supply inventory. Get this defined in your Letter of Intent (LOI), not at closing.

What are the tax consequences of selling a dental practice to a DSO?

The tax structure of a dental practice sale depends heavily on your entity type (S-corp, C-corp, PLLC, sole proprietor), the allocation of purchase price across asset classes (goodwill, equipment, non-compete, employment agreement), and whether you take rollover equity. Federal capital gains rates in 2026 top out at 20% plus the 3.8% Net Investment Income Tax for a total of 23.8% on long-term capital gain from goodwill sale, versus ordinary income rates up to 37% on personal service compensation (IRS Topic 409 Capital Gains; IRS Net Investment Income Tax). State tax adds 0-13.3% depending on residence (Tax Foundation state individual income tax rates).

Goodwill allocation: personal versus corporate

For a C-corp or S-corp dental practice sold as an asset deal, the largest tax opportunity is the personal goodwill argument established in Martin Ice Cream Co. v. Commissioner (110 T.C. 189, 1998) and confirmed in Bross Trucking, Inc. v. Commissioner (T.C. Memo. 2014-107). Personal goodwill (tied to the selling dentist’s personal reputation, patient relationships, and referral network) is taxed at long-term capital gains rates at the shareholder level and does not go through the corporation. Corporate goodwill is taxed inside the corporation first, creating double taxation for C-corps.

Well-drafted purchase agreements for dental deals typically allocate 60-85% of price to personal goodwill, with corporate goodwill, equipment (Section 1245), and non-compete (Section 197 amortized over 15 years for buyer, ordinary income for seller) filling out the rest. IRS Form 8594 Asset Acquisition Statement must be filed by both buyer and seller reporting matching allocations. Get a valuation appraisal supporting the allocation before closing to strengthen your position on IRS audit.

Section 1202 QSBS treatment (100% federal capital gains exclusion up to $10M or 10x basis) does not apply to dental practices because Section 1202 excludes any trade or business involving the performance of services in the field of health (IRC Section 1202(e)(3)(A)). This is different from the C-corp asset sale mechanics for non-healthcare businesses. See QSBS Section 1202 for the general rules, then get a tax attorney with health-care M&A experience.

Rollover equity as tax-deferred consideration

Structured properly (typically as an equity contribution to a partnership under IRC Section 721, or a Section 351 exchange into a corporation), rollover equity into a DSO holdco can be tax-deferred until the rollover shares are later sold or exchanged. This lets you defer tax on the rollover portion of your proceeds, at the cost of continued exposure to the DSO’s success. Your tax attorney and M&A advisor need to model post-close ordinary income (employment compensation for continuing dentists) versus capital gain (goodwill and rollover) allocations before you sign the LOI, not after.

How much does an M&A advisor charge to sell a dental practice?

M&A advisor fees for a dental practice sale typically fall in three structures: a straight Lehman-formula success fee (5-4-3-2-1% on descending tranches of price), a modified Double or Triple Lehman (10-9-8-7-6% or 12-11-10-9-8%), or a fixed monthly retainer of $10,000-$30,000 plus a 2-5% success fee. Boutique dental brokers on solo practices typically charge 8-10% of gross price with no retainer.

Fees vary by deal size. Larger deals ($10M+ enterprise value) command lower percentage fees because the absolute dollar fee is still meaningful. Sub-$5M dental deals often carry higher percentage fees because the fixed workload of running a sell-side process does not scale down linearly. See M&A advisor cost for detailed fee ranges by enterprise value tier and business broker fee structures for the lower end of the market.

Typical dental M&A engagement terms

Deal size (EV) Fee structure Retainer Success fee Tail period
Under $2M Broker % of price $0-$5K 8-10% 12-24 months
$2M-$5M Modified Lehman $5K-$15K monthly 4-6% 18-24 months
$5M-$15M Retainer + success $10K-$25K monthly 3-5% 24 months
$15M-$50M Retainer + success $15K-$30K monthly 2-4% 24-36 months
$50M+ IB retainer + success $25K-$50K monthly 1-3% 24-36 months

The “tail period” clause means if you close a deal with any buyer your advisor introduced during the engagement (within 12-36 months of termination), the success fee still applies. Read this section carefully before signing, and negotiate a defined buyer list rather than an open-ended definition.

Which M&A firms and brokers actively sell dental practices in 2026?

The dental M&A market has three distinct advisor tiers: dental-specialty brokers (single-office solo practice transactions), boutique dental M&A firms (multi-office groups up to $50M EV), and healthcare-focused middle-market investment banks (platform deals $50M+ EV). Choosing the right tier for your practice size determines whether you get an efficient auction or a mismatched process.

Dental-specialty brokers (solo practice transactions)

These firms are efficient at what they do (moving sub-$1.5M-collections solo practices to individual dentist buyers) but generally do not run competitive DSO auctions.

Boutique dental M&A firms (multi-office and DSO-track transactions)

Healthcare-focused middle-market investment banks (platform deals)

Your practice size determines the correct tier. A $2M-EBITDA two-office group hiring Houlihan Lokey will not get senior attention and may be turned away. A $12M-EBITDA regional group hiring a solo-practice broker will leave millions on the table by not running a real DSO auction.

How do I actually choose the right M&A advisor for my dental practice?

Pick your dental practice M&A advisor by (1) matching firm size to your deal size, (2) verifying dental-vertical transaction volume in the past 24 months, (3) requesting the specific DSO buyer relationships they have, (4) checking references from three prior selling dentists (not the firm’s marketing testimonials), (5) reading the engagement letter for tail period, exclusivity, and fee triggers, and (6) meeting the actual banker who will run your process, not the senior partner who pitched you.

Diligence questions to ask before signing the engagement letter

  1. How many dental practice transactions have you closed in the past 24 months? Segment by solo, group, and DSO-track.
  2. Which DSOs have you sold practices to in the past 24 months? Ask for named buyers (they can decline to name specific dentist-sellers for confidentiality but should name buyers).
  3. Will the person I am meeting today run my process, or will I be handed to a junior associate after the engagement letter is signed? Get this in writing.
  4. What is your average process timeline from engagement to close? Realistic answer for a dental group is 6-10 months.
  5. What is your success rate on deals engaged in the past 24 months (deals closed / deals engaged)? Legitimate firms will answer 65-85%.
  6. Will you provide a written pre-engagement valuation opinion with supporting comparables?
  7. What is your tail period, and can you provide a defined named-buyer list rather than open-ended?
  8. Do you take referral fees, kickbacks, or side compensation from DSO buyers? The answer must be no in writing.
  9. What is your typical retainer structure and is any portion refundable or creditable against success fee at close?
  10. Provide three references from selling dentists whose deals closed in the past 18 months.

Red flags that should disqualify an advisor immediately

What does a dental practice sell-side process actually look like, step by step?

A dental practice sell-side M&A process runs in six phases over 6 to 10 months: preparation and QoE (weeks 1-8), CIM and buyer list creation (weeks 6-10), first-round buyer outreach and indications of interest (weeks 10-16), management presentations and LOI negotiation (weeks 14-20), exclusive due diligence (weeks 18-28), and closing plus post-close integration (weeks 26-40). Compressed timelines increase valuation risk.

Phase 1: Preparation and quality of earnings (weeks 1-8)

The advisor works with your accountant to normalize three years of financials, run add-back analysis, prepare a defensible adjusted EBITDA number, and commission a third-party QoE. A separate collections-and-recall analysis quantifies new-patient acquisition, active-patient count, hygiene reappointment rate, and case-acceptance percentage. Corporate housekeeping (licenses current, no lapsed insurance, DEA registrations, HIPAA policies documented, employee agreements assignable) happens in parallel.

Phase 2: CIM and buyer list (weeks 6-10)

The advisor drafts a 30-60 page Confidential Information Memorandum (CIM) covering practice history, services, staff, patient demographics, insurance mix, financial performance, real estate, growth opportunities, and reason for sale. A buyer list of 30-100 targeted DSOs, PE-backed platforms, family offices, and strategic acquirers is built with your approval (you can veto specific buyers for competitive, personal, or reputation reasons).

Phase 3: First-round outreach and IOIs (weeks 10-16)

Non-disclosure agreements are executed with each interested buyer, followed by CIM distribution. Interested buyers submit non-binding Indications of Interest (IOIs) with proposed price range, cash-versus-rollover mix, key contingencies, and desired timing. Your advisor tables the IOIs, ranks by price and structure, and narrows to 5-10 buyers who advance to management presentations.

Phase 4: Management presentations and LOI (weeks 14-20)

Each shortlisted buyer conducts a 3-4 hour management presentation (typically in-person or virtual) with the selling doctors and CFO. Buyers submit revised Letters of Intent, which are binding on process rules (exclusivity, timing) but non-binding on price until definitive agreements are signed. Your advisor negotiates the LOI heads of terms, then you enter a 30-60 day exclusivity period with one buyer.

Phase 5: Exclusive due diligence (weeks 18-28)

The buyer runs financial, tax, legal, regulatory (HIPAA, OSHA, dental licensing), real estate, insurance, IT, and clinical due diligence. Your advisor and attorney negotiate the Asset Purchase Agreement (APA) or Stock Purchase Agreement (SPA), the employment and non-compete agreements for continuing dentists, the MSO/PC support services agreement, the rollover equity documents, the escrow agreement, and the working capital true-up mechanics. This is the phase where deals most commonly re-trade on price (10-25% multiple compression is not unusual if diligence surprises emerge).

Phase 6: Signing, closing, and integration (weeks 26-40)

Definitive agreements are signed, followed by a 30-90 day period to satisfy closing conditions (regulatory notices, insurance credentialing, lender consents, real estate lease assignments or new leases). Closing wires flow, and you enter a defined post-close employment or transition period (typically 2-5 years for the selling doctor, longer for younger associate dentists staying in the practice).

How does clinical autonomy work post-close in a DSO acquisition?

Clinical autonomy under a DSO structure is legally protected by the MSO/PC split: your Professional Corporation, owned by licensed dentists, retains all clinical decision-making, patient care protocols, and treatment planning authority. The DSO Management Services Organization owns and operates all non-clinical functions (billing, HR, IT, procurement, real estate, marketing, back-office finance) under a Management Services Agreement (MSA) with the PC. The ADA’s position statement on corporate practice reinforces the requirement that clinical judgment remain with the licensed dentist (ADA current policies).

In practice, clinical autonomy is real but bounded. The PC controls treatment recommendations and patient care standards. The DSO controls insurance participation decisions, fee schedules within insurer contracts, scheduling software, and referral patterns to specialists inside the DSO’s network. Contractually protecting your continuing autonomy on specific practices you care about (materials brands used, lab selection, minimum appointment time, staff-to-provider ratios) requires those specifics to be written into the MSA, not left to post-close operational discretion.

State regulatory scrutiny of DSO clinical control has intensified. Attorneys general in California, New York, Massachusetts, and Colorado have opened investigations into whether specific DSO structures effectively control clinical decisions in violation of corporate-practice-of-dentistry statutes. The Federal Trade Commission has also examined healthcare consolidation, including a July 2023 policy statement on healthcare mergers (FTC healthcare policy actions). Your M&A advisor should flag any buyer’s MSA structure that has attracted regulatory scrutiny before you sign an LOI.

How CT Acquisitions approaches dental practice sales

CT Acquisitions is a lower-middle-market sell-side and buy-side M&A advisor. Our dental practice engagement approach centers on aligning economically with the seller: transparent monthly retainers credited against success fee at close, no side compensation from buyers, defined tail-period buyer lists rather than open-ended clauses, and direct senior banker relationships (the person you meet in the pitch is the person who runs your process).

For dental practice sellers with $750K+ adjusted EBITDA or two-plus locations, our value is: (a) a curated auction across 30-60 named DSO, PE-backed platform, family office, and strategic buyer contacts, (b) a defensible pre-engagement valuation opinion with dental-vertical comparables, (c) LOI-stage negotiation of rollover terms, earnout mechanics, and escrow before exclusivity, (d) coordination with tax counsel on personal goodwill allocation and rollover Section 721/351 structuring, and (e) documented seller-side reference calls with prior selling dentists on request.

We do not turn away sub-$50M enterprise value deals in dental or other lower-middle-market verticals. Larger bulge-bracket firms often do. If your deal is large enough that a Houlihan Lokey or Piper Sandler is the correct fit (platform deals with $10M+ EBITDA and a defined path to a $200M+ DSO exit), we will tell you so. Trust is built by giving you the honest answer for your situation.

See sell-side advisory maximize your exit value for our full sell-side engagement model. To discuss whether your dental practice is a fit, schedule a 30-minute exit-readiness call at ctacquisitions.com/contact-us.

Common mistakes dental practice sellers make (and how to avoid them)

  1. Selling to the first inbound DSO offer. DSO business development teams cold-call practices constantly. A first offer represents the buyer’s low-anchor bid, not fair market value. Running a competitive process typically adds 15-40% to headline price and 25-60% to net after-tax proceeds.
  2. Not getting a pre-sale quality of earnings. Buyers will run a QoE regardless. Your leverage is highest when your own QoE precedes theirs.
  3. Underestimating rollover risk. Rollover equity is not cash. Model the DSO’s leverage, growth trajectory, and exit timing before committing 20-30% of your proceeds to holdco shares.
  4. Ignoring tax structure until after LOI. Personal goodwill allocation, Section 721 rollover structure, and state tax planning need to be locked before signing the LOI. Fixing tax structure afterwards costs 3-8% of proceeds.
  5. Signing an engagement letter with an open-ended tail period. Insist on a defined named-buyer list.
  6. Not verifying the actual banker running your process. Pitch teams and execution teams are often different. Get the working team in writing before signing.
  7. Underpricing the transition employment period. Continuing dentists’ compensation post-close needs to be negotiated as part of total consideration, not treated as a separate HR matter.
  8. Assuming DSO diligence is a formality. Buyers will strip aggressive add-backs, retrade on undisclosed liabilities, and adjust price for retention risk. Prepare for it.
  9. Sharing rollover DSO documentation without independent counsel. The DSO’s shareholders agreement, put/call terms, and information rights need review by counsel who represents you, not the DSO.
  10. Signing without a real reference call. Talk to three selling dentists whose deals closed in the past 18 months, ideally at similar practice size to yours.

Frequently Asked Questions

How much can I sell my dental practice for in 2026?

Solo general dental practices in 2026 typically sell for 4x-7x adjusted EBITDA to DSO buyers, or 60-80% of annual collections when sold to individual dentist buyers. Multi-doctor groups with $1M-$3M in adjusted EBITDA range from 7x-9x. Regional groups with five or more locations range from 8x-11x. Specialty practices (orthodontics, oral surgery, endodontics, pediatric) command a one-to-three-turn premium over general dentistry. Actual price depends on geography, insurance mix, doctor tenure post-close, and buyer competition.

Do I need a broker or M&A advisor to sell my dental practice?

For a solo practice under $500K in collections sold to an individual dentist, a dental broker (Henry Schein PPT, ADS Transitions) is usually sufficient and cost-effective. For any practice with over $750K adjusted EBITDA, two or more locations, or DSO buyer interest, hire a dental-fluent M&A advisor to run a competitive auction. The multiple you realize typically increases by 15-40% versus a single-buyer negotiation, and deal structure (rollover, earnout, escrow) requires professional negotiation.

What is a DSO, and should I sell to one?

A Dental Service Organization is a corporate entity that owns non-clinical practice operations (billing, HR, procurement, real estate, marketing) under a management services agreement with a dentist-owned Professional Corporation that retains clinical control. Selling to a DSO makes sense if you have $750K+ adjusted EBITDA, are willing to continue clinical practice for 2-5 years post-close, and are comfortable with 15-30% rollover equity for a paper “second bite.” If you want a clean full-cash exit, a smaller regional DSO or individual dentist buyer may fit better.

How long does it take to sell a dental practice to a DSO?

A dental practice sell-side process typically runs 6-10 months from engagement letter to close: 6-8 weeks for preparation and QoE, 4-6 weeks for CIM drafting and buyer list, 6-8 weeks for first-round buyer outreach and IOIs, 4-6 weeks for management presentations and LOI, 8-12 weeks of exclusive due diligence and definitive agreements, then 4-8 weeks of closing conditions and integration planning. Rushing the process below 6 months typically compresses valuation.

What multiple do specialty dental practices sell for?

Orthodontic practices in 2026 typically sell at 7x-13x adjusted EBITDA depending on scale, oral surgery groups at 10x-14x, endodontic groups at 9x-13x, and pediatric dental groups at 8x-12x. Specialty practices trade at a one-to-three-turn premium to general dentistry due to higher operating margins, stickier patient bases, and greater consolidation activity from PE-backed specialty roll-ups (US Endo Partners, Beacon Oral Specialists, OrthoDent, US Oral Surgery Management).

What are the tax consequences of selling my dental practice?

Federal tax on dental practice sale proceeds depends on entity type, price allocation, and rollover structure. Long-term capital gain on personal goodwill is taxed at 20% plus the 3.8% Net Investment Income Tax at the shareholder level. Ordinary income items (non-compete allocation, employment compensation) are taxed at rates up to 37%. State tax adds 0-13.3%. Section 1202 QSBS treatment does not apply to dental practices because they are health-services businesses. Personal goodwill allocation typically saves 15-25% of tax versus a full corporate-goodwill treatment for C-corps and S-corps.

What is rollover equity in a DSO deal, and is it worth taking?

Rollover equity is the portion of your sale proceeds you reinvest into equity of the acquiring DSO’s parent holding company, typically 15-30% of total consideration for group practices. The upside is a paper “second bite” at the DSO’s eventual exit multiple; realized outcomes have ranged from 2x-5x on rollover dollars in successful DSO exits to write-downs or delayed liquidity when platforms underperform. Take rollover if you believe in the DSO’s growth and can afford the illiquidity for 3-7 years. Take cash if you want certainty.

Do M&A advisors work for the buyer or the seller?

A legitimate sell-side M&A advisor works exclusively for the seller and owes fiduciary-style duties to maximize your outcome. Reputable firms will not represent buyers on the same transaction or take referral fees from DSO acquirers. If a firm represents both buyers and sellers on dental transactions, that is a business broker practice model that should disqualify them from running your competitive auction. Ask for a written confirmation of exclusive seller representation and no buyer-side compensation before signing the engagement letter.

Leave a Reply

Your email address will not be published. Required fields are marked *

CT ACQUISITIONS

Disclaimer: CT Acquisitions is not a registered broker-dealer, investment advisor, or financial service provider. We act solely as a buy-side consultant and independent sponsor source. All information provided on this website is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or investment opportunity. We do not provide legal, tax, or accounting advice. Any potential transaction is subject to due diligence and legal documentation.

© 2025 CT Acquisitions. All Rights Reserved.